Related Experiment Videos

Dilated cardiomyopathy in haemophiliacs infected with the human immunodeficiency virus

A J Jacob1, G R Sutherland, N A Boon

  • 1Department of Cardiology, Royal Infirmary, Edinburgh.

Insights

Human immunodeficiency virus (HIV) infection can cause dilated cardiomyopathy. This study highlights two cases in Scottish hemophiliacs who developed this heart condition after HIV infection from contaminated factor VIII treatment.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Hematology

Background:

  • Human immunodeficiency virus (HIV) infection is associated with various cardiac abnormalities.
  • Dilated cardiomyopathy is a known complication of HIV, observed across different transmission routes.
  • Previous cases involved sexual intercourse, injection drug use, and vertical transmission.

Purpose of the Study:

  • To report and discuss two cases of dilated cardiomyopathy in hemophiliacs with HIV infection.
  • To investigate the link between HIV acquired through contaminated factor VIII treatment and cardiac complications.
  • To highlight a specific risk factor for dilated cardiomyopathy in the context of hemophilia and HIV.

Main Methods:

  • Case study identification of two Scottish hemophiliacs.
  • Review of medical history focusing on HIV acquisition and cardiac health.
  • Clinical assessment and diagnosis of dilated cardiomyopathy.

Main Results:

  • Two Scottish hemophiliacs with HIV infection were identified.
  • Both patients developed dilated cardiomyopathy.
  • HIV infection was acquired through treatment with contaminated factor VIII concentrate.

Conclusions:

  • Contaminated factor VIII treatment is a potential route for HIV acquisition leading to dilated cardiomyopathy in hemophiliacs.
  • This finding underscores the importance of screening and safety in blood product treatments.
  • Further research may be warranted to understand the specific mechanisms involved.

Related Concept Videos